Dofetilide
Dofetilide is a selective potassium channel ((hERG) ) blocker, used as a Class III antiarrhythmic drug. (In Vitro) :Dofetilide (3~100 μg/kg; i.v.) increases repolarisation time via a selective prolongation of activation repolarisation interval, activation time being unchanged.Dofetilide is metabolized by CYP3A4 to a mixture of inactive polar metabolites that are then excreted by the kidney.
Product Specifications
CAS Number
115256-11-6
Product Name Alternative
Tikosyn | UK 68789
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO:88 mg/mL warmed (199.29 mM) ; Ethanol:<1 mg/mL (<1 mM) ; Water:<1 mg/mL (<1 mM)
Smiles
CS (=O) (NC1=CC=C (OCCN (CCC2=CC=C (NS (=O) (C) =O) C=C2) C) C=C1) =O
Molecular Formula
C19H27N3O5S2
Molecular Weight
441.56
References & Citations
JJA Bavel et al Drug and device testing in a preclinical model sensitive to cardiac arrhythmias dspace.library.uu.nl, (2023)
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
N- (4- (2- (methyl (2- (4- (methylsulfonamido) phenoxy) ethyl) amino) ethyl) phenyl) methanesulfonamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human BTLA shRNA (UAS) - Lentiviral human BTLA shRNA (UAS, RFP) (25)
![(3S)-1-Azabicyclo[2.2.2]octan-3-ol](https://cdn.genprice.uk/products/572/128173802972/imageurl/trc-a795295-500mg.webp)